The Health-Related Quality of Life of Patients with Prostate Cancer and Their Spouses before Treatment Compared with the General Population by Harju, Eeva et al.
HRQoLofPatientswithPCsandSpouses ͳ


The Health-Related Quality of Life of Patients with Prostate Cancer and Their Spouses 
before Treatment Compared with the General Population 
Eeva HARJU, MNSc, RN                                             (correspondence) 
Doctoral Candidate  
Faculty of Social Sciences, Nursing Science, University of Tampere, Finland 
Email address: eeva.j.harju@uta.fi 
postal address: Arvo, FI-33014 University of Tampere, Finland 
telephone number: +358503187632 
Anja RANTANEN, PhD, RN  
Docent, University Teacher 
Faculty of Social Sciences, Nursing Science, University of Tampere, Finland 
Email address: Anja.Rantanen@uta.fi 
Postal address: Arvo, FI-33014 University of Tampere, Finland 
Telephone number: +358401901452 
This is the peer reviewed version of the following article: The health‐related qual-
ity of life of patients with prostate cancer and their spouses before treatment compared with the 
general population. International Journal of Nursing Practice. 2017. Vol. 23, no.5, e12572. It has 
been published in final form at http://dx.doi.org/10.1111/ijn.12572.
HRQoLofPatientswithPCsandSpouses ʹ


Marja KAUNONEN, PhD, RN  
Professor  
Faculty of Social Sciences, Nursing Science, University of Tampere, Finland 
Email address: Marja.Kaunonen@uta.fi 
Postal address: Arvo, FI-33014 University of Tampere, Finland 
Telephone number: +358401901454 
Department of General Administration, Pirkanmaa Hospital District, Finland 
Postal address: PO Box 2000, FI-33521 Tampere University Hospital, Finland 
Mika HELMINEN, MSc  
Biostatistician 
Faculty of Social Science, University of Tampere, Finland 
Email address: Mika.Helminen@uta.fi 
Postal address: Arvo, FI-33014 University of Tampere, Finland 
Telephone number: +358401901599 
Science Centre, Pirkanmaa Hospital District, Finland 
Postal address: PO Box 2000, FI-33521 Tampere University Hospital, Finland 
Taina ISOTALO, M.D., PhD  
Chief Urologist 
Department of Surgery, Päijät-Häme Central Hospital, Lahti, Finland  
Email address: Taina.Isotalo@phsotey.fi 
Postal address: Keskussairaalankatu 7, FI-15850 Lahti, Finland 
Telephone number: +358381911 
HRQoLofPatientswithPCsandSpouses ͵


Päivi ÅSTEDT-KURKI, PhD, RN  
Professor 
Faculty of Social Sciences, Nursing Science, University of Tampere, Finland 
Postal address: Arvo, FI-33014 University of Tampere, Finland 
Telephone number: +358505954516 
Department of General Administration, Pirkanmaa Hospital District, Finland 
Postal address: PO Box 2000, FI-33521 Tampere University Hospital, Finland 
ACKNOWLEDGEMENTS 
This study was supported by grants from the School of Health Sciences (University of 
Tampere), Finnish Association of Urological Nurses, Finnish Foundation of Urological 
Research and Nursing Foundation of the Pirkanmaa Hospital District.  
Authorship statement 
All listed authors meet the authorship criteria and they are in agreement with the content of 
the manuscript. 
ABSTRACT  
Aims: To describe the health-related quality of life (HRQoL) of patients with prostate cancer 
and their spouses in comparison with the Finnish general population, using the RAND-36-
Item Health Survey. An additional purpose was to describe the associations between the 
background variables of the participants and their HRQoL.  
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Background: The HRQoL of patients with prostate cancer and especially their spouses at the 
time of diagnosis is not well known.  
Design: A cross-sectional study. 
Methods: Responses were received from 232 patients and 229 spouses at five central hospitals 
in Finland between October 2013 and January 2016. 
Results: Compared to the Finnish general population mean, the HRQoL of the patients and 
their spouses was, on average, better for all dimensions. Patients’ age, the presence of disease 
and the treatment method were associated with the dimensions of HRQoL. The dimensions of 
HRQoL were also associated with spouses’ age, basic and vocational education and the 
presence of disease.  
Conclusion: The patients and their spouses experienced their HRQoL as very similar; 
however, on average, it is better than the general population mean. However, the evidence 
suggests that support from the nurses should focus on emotional well-being, the dimension 
that received the lowest scores in both groups.  
 
SUMMARY STATEMENT  
 
Whatisalreadyknownaboutthistopic?
x The incidence rates of prostate cancer have increased  
x Prostate cancer and its treatments affect patients’ quality of life.  
x The HRQoL of spouses at the time of diagnosis is unclear in the literature. 

Whatthispaperadds:
x At the time of diagnosis, the HRQoL of the patients with prostate cancer and their 
spouses was better than the age- and gender-stratified Finnish population. 
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x The HRQoL of the patients and their spouses did not differ from each other at the time 
of diagnosis. 
x The demographic factors of spouses including age, basic education, vocational 
qualifications and chronic diseases were associated with spouses physical functioning, 
physical and emotional role functioning, bodily pain and general health. 

Theimplicationsofthispaper:
x Nurses should pay more attention to the emotional role functioning of spouses as part 
of good prostate cancer care. 
x Nurses should particularly take into consideration the physical functioning of patients 
who are more than 70 years old, treated with hormone therapy and have an earlier 
disease.
x Nurses can develop and implement interventions based on knowledge about the 
HRQoL of these patients and their spouses. 
 
Keywords: prostate cancer, quality of life, spouses 
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INTRODUCTION  
  
The incidence of prostate cancer has increased rapidly and an estimated 1.1 million men 
worldwide were diagnosed with prostate cancer in 2012 (Ferlay et al. 2015). Prostate cancer is 
presently the most common type of cancer among men in developed countries as well as in 
the Finnish men. More than 4700 Finnish men, who are mostly over 70 years of age, are 
diagnosed with prostate cancer each year (Engholm et al. 2015, Ferlay et al. 2015). Most 
Finnish men with prostate cancer live together with their spouses (Lehto et al. 2015). 
Therefore, prostate cancer in a family member affects the whole family. Together with the 
cancer symptoms, the side effects of treatment may lead to psychological distress and 
impaired functional capacity, reducing psychological well-being and quality of life 
(Northouse et al. 2007, Sanda et al. 2008, Harden et al. 2013b).  
 
The most typical symptoms caused by active treatment of prostate cancer are urine 
incontinence and sexual problems. In addition, hormonal treatment may cause physical and 
psychological symptoms. Because the symptoms are deeply personal matters, they may cause 
psychological and social problems that might not be recognized (Sanda et al. 2008, Roth et al. 
2008, Huang et al. 2010, Mc Caughan et al. 2013, Lehto et al. 2015). Mutual psychological 
distress of patients with prostate cancer and their spouses can lead to a poor quality of life 
(Kim et al. 2008). The absence of a spouse appears to be a risk factor for poor quality of life 
in men on active surveillance (Bellardita et al. 2014). Single men reported a lower quality of 
life one year post treatment than married men (Dieperink et al. 2012, Mc Caughan et al. 
2013). On the other hand, marital discord can also weaken HRQOL of patients with prostate 
cancer (Merz et al. 2011).   
 
HRQoLofPatientswithPCsandSpouses ͹


Health-related quality of life  
The concept of quality of life has become significant in relation to health because there are an 
increasing numbers of individuals living with long-term illnesses (Eton & Lepore 2002). The 
quality of life represents an individual’s idea of his or her situation in life in that set of values 
and in the cultural context in which the person lives (The WHOQOL Group, 1998). Quality of 
life includes an individual’s physical health, psychological functioning, degree of the 
independence, social relations and his /her relation with the environment (The WHOQOL 
Group, 1998). HRQoL is specified in this study, which includes individuals’ physical, 
psychological and social ability to function and welfare and it is dealt with from the points of 
view of prostate cancer patients and of their spouses (Aalto et al. 1999, Bowling 2004). It has 
been stated that prostate cancer and its treatments will affect the patients’ as well as the 
spouses’ quality of life (Maliski et al. 2002, Sanders et al. 2006, Harden et al. 2008, Kim et al. 
2008).  
 
Combined treatments and use of medication have been associated with worse physical and 
role functioning among patients with prostate cancer (Green et al. 2011). Ratings for physical 
and social functioning are the highest among the subscales for HRQoL before treatment 
(Green et al. 2011, Vasarainen et al. 2013, Paterson et al. 2015), while global quality of life / 
general health and vitality are the weakest subscales (Green et al. 2011, Vasarainen et al. 
2013, Cary et al. 2014). Three months following the prostate cancer treatment, patients 
reported that physical functioning, energy and general health were lower when compared to 
other items on a generic HRQoL scale. They had been treated for radical prostatectomy, 
radiation therapy, hormonal therapy or watchful waiting. Among prostate-specific HRQoL 
subscales, sexual function and sexual scores are lower compared with other scales 
(Jayadevappa et al. 2012). Patients with prostate cancer are more worried about their sexual 
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disability than their spouses (Burt et al. 2005, Couper et al. 2006, Merz et al. 2011). 
Furthermore, when compared to the general population, the HRQoL of patients with prostate 
cancer remained at a relatively high level as long as the cancer remains localized (Torvinen et 
al. 2013). Impotence, loss of libido, incontinence and fatigue resulting from treatment affect 
the lives of both patients and their spouses and can reduce the quality of life of both (Navon & 
Morag 2003, War-Smith & Kapitan 2005, Yang et al. 2005). At the time of the prostate 
cancer diagnosis, little is known about the spouses’ quality of life. Patients’ and their spouses’ 
quality of life is reported more after the primary treatment of prostate cancer.  
 
In previous studies, factors related to the socioeconomic background of patients with prostate 
cancer, such as income and education have been related to HRQoL. Patients with low 
socioeconomic background have reported low HRQoL as well. Therefore, they are in greater 
need of guidance from the nurses (Penson et al. 2001, Rayford 2006). In addition to age and 
symptoms, financial difficulties seemed to be the most important determinant related to the 
poor HRQoL of patients with prostate cancer (Torvinen et al. 2013). However, the connection 
between patients’ socioeconomic background and quality of life is not necessarily this 
unambiguous (Maliski et al. 2011). According to a cross-sectional study (Green et al. 2011), 
high education is associated with better role functioning and reduced fatigue. 
 
Spouses’ younger age and lower income have been associated with greater distress and poorer 
quality of life (Deimling et al. 2002, Harden et al. 2013b, Wu & Harden 2015). Likewise, 
spouses who have low education reported distress regarding their husbands’ prostate cancer 
(Eton & Lepore 2002). Spouses expressed ongoing worries about their husbands’ illness those 
worries were associated with their sense of well-being and sleep, which may then affect the 
spouses’ appraisals of their husbands’ illness and in turn the spouses’ own quality of life 
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(Harden et al. 2006). After prostate cancer treatment problems related to the changes in the 
sexual relationship were reported more by spouses than patients (Harden et al. 2008). The 
spouses try to retain emotional balance and try to maintain a positive attitude because they are 
the most important support for the patient. At the same time, spouses reported patients’ social 
functioning as significantly better and emotional functioning as significantly worse than the 
patients’ own ratings (Green et al. 2011).  
 
Although, the number of patients with prostate cancer has increased steadily during the last 
two decades, there is little knowledge of patients’ and spouses’ HRQoL before the start of 
cancer treatment. There is also a lack of knowledge on the ways in which their HRQoL differs 
from that of the general population. This knowledge is needed for the further development of 
nursing of patients with prostate cancer and their family. 
 
METHODS 
 
Aims 
The aim of this study was to examine the HRQoL of patients with prostate cancer and their 
spouses before treatment of prostate cancer in comparison with the general population. 
Furthermore, this study investigated the demographic variables associated with the HRQoL in 
patients with prostate cancer and their spouses.  
 
Design 
This cross-sectional study is a part of a longitudinal study. Data were collected from newly 
diagnosed patients with prostate cancer and their spouses before the start of prostate cancer 
treatment.  
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Participants 
The study sample consisted of 350 consecutive new patients with prostate cancer and their 
spouses regardless of the prospective treatment of prostate cancer. The inclusion criterion was 
men diagnosed with prostate cancer, prior to the beginning of treatment. Men characterized 
the relationship to their spouse as permanent and provided written informed consent with the 
additional contact information for their spouse. The enrolled patients received questionnaire 
forms for both themselves and their spouses, with a return envelope, during their appointment 
with a nurse. The completed questionnaires were mailed to the researcher’s office. If neither 
the patient nor the spouse returned the questionnaire, they did not receive the follow-up 
questionnaire.  
 
The sample size was calculated together with a statistician. In previous studies (Osoba et al. 
2005), clinically significant change in health-related quality of life scores was determined at 
10 points. The sample size calculation was based on paired-samples t-test. Using a standard 
deviation of 20, with the alpha value set at 0.05 and the power at 0.8, a change of 10 points 
was calculated to be statistically significant with a sample of 33 respondents (Osoba et al. 
2005). Assuming that approximately half of the participants would complete the survey, the 
figure was rounded to 70 patients. In addition, the patients might receive at least four types of 
treatment, in five different hospitals. Thus, the questionnaire was distributed to 350 patients 
and their spouses (N=350). 
 
Data collection 
Recruitment was done at the urology clinics of five Finnish central hospitals between October 
2013 and January 2016. In the participating hospitals, altogether 800-900 new patients with 
prostate cancer are being treated every year. 
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RAND-36 – Item Health Survey 
The Finnish version of the RAND-36-Item Health Survey (RAND-36) was used to measure 
both patients and spouses’ perspectives on HRQoL. The RAND-36 utilizes exactly the same 
questions as the Medical Outcome Study SF-36 (MOS SF-36); however, the scoring of 
general health and bodily pain does differ slightly for the MOS SF-36 (Ware & Sherbourne 
1992, Hays et al. 1993). The RAND-36 consists of a total of 36 items divided into eight 
subscales: physical functioning, bodily pain, role limitations due to emotional/physical 
problems, emotional well-being, social functioning, energy/fatigue and general health 
perceptions (Aalto et al. 1999).  Each subscale with higher scores indicates better 
corresponding HRQoL domain (Ware & Sherbourne 1992).  The RAND-36 is an 
internationally used instrument in measuring the HRQoL of patients with prostate cancer and 
their spouses (Treiyer et al. 2011, Dieperink et al. 2012b, Vasarainen et al. 2013, Harden et al. 
2013a, Cary et al. 2014). In international surveys on patients with prostate cancer, the 
coefficients have been over 0.88 (Harden et al. 2013). The reliability of the instrument has 
been tested in Finland, with Cronbach’s alpha coefficients for internal consistency at 0.80–
0.94 (Aalto et al. 1999). To allow comparison with the general population, age-stratified 
reference values for the subscales have been established (Aalto et al. 1999, Vasarainen et al. 
2013). The samples of the general population were randomly selected from the Finnish 
Population Register. The response rate was 64 % (n=2175) (Aalto et al. 1999). 
 
Demographic characteristics 
The demographic characteristics of participants included age, duration of the marital 
relationship, basic and vocational education, employment status and chronic diseases. In 
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addition, among the patients’ demographic characteristics were the hospital where the prostate 
cancer was diagnosed and treated and the treatment methods for the cancer.  
 
Ethical considerations 
The ethicality of this study was approved by the Scientific Committee of the local hospital 
district. The directors of the five participating hospitals permitted its execution. All 
respondents were informed in writing and orally of the purpose of the study and of the 
principle of voluntary, anonymous participation.   
 
Data analysis 
Standard methods were used for the descriptive statistics mean and standard deviation. The 
quality of life subscales of the RAND-36 were scored in two phases. First, the numeric values 
given in the questionnaire were recoded according to the scoring instructions of the 
instrument. Second, summated variables of the eight subscales were formed from the indices. 
All eight subscales are separately scored from 0 to 100, with higher scores indicating better 
HRQoL (Aalto et al. 1999).  All eight dimensions did not meet the assumption of normality, 
using the Spearman’s rank correlation, Wilcoxon Signed Ranks, Mann-Whitney, and Kruskal-
Wallis tests to examine associations. These were followed by post hoc comparisons using 
Bonferroni adjustment to determine where the change occurred. The internal consistency of 
the summated variables was tested using Cronbach´s alpha coefficients (Burns & Grove 
2009). All analyses were carried out using IBM SPSS statistics Version 23 (IBM Corp., 
Armonk, NY, USA). The level of statistical significance was set at p<0.05. 
 
 
 
HRQoLofPatientswithPCsandSpouses 13


RESULTS 
 
Demographic characteristics of respondents 
Responses were received from 232 patients and 229 spouses. The overall response rate was 
65%. The mean age of the patients with prostate cancer was 68 years (SD=8.4), ranging from 
40 to 86 years (Table 1). The marital relationship of the participants was an average of 36 
years (SD=16.0). The shortest marital relationship was less than one year and the longest was 
61 years. More than two-thirds of the patients with prostate cancer had completed elementary 
school or civic school and more than half were not working. More than one-third of the 
patients had no other disease in addition to prostate cancer. The prostate cancer of one-third of 
the patients would initially be treated by surveillance, i.e. the patient would receive non-
invasive care.  
 
The ages of the spouses ranged from 33 to 85, with a mean age of 65 years (SD=9.0). Nearly 
half of the spouses had completed either elementary school or civic school. One-fourth of the 
spouses had no vocational qualification and half of them were not working. More than two-
thirds of the spouses had a chronic disease (cardiovascular diseases, diabetes, chronic lung 
disease and musculoskeletal disorders) (Table 1).  
 
Health-related quality of life  
Based on the average value, the HRQoL of the patients with prostate cancer and their spouses 
was best on the dimensions of social and physical functioning (Table 2). Compared to the 
age- and gender-stratified Finnish population mean, HRQoL of the patients with prostate 
cancer was on average better on all dimensions. The difference between the means was 
statistically significant on all dimensions of HRQoL. Spouses’ HRQoL was on average better 
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on all eight dimensions compared to the age- and gender-stratified mean Finnish population. 
The difference between the means was statistically significant. Correspondingly, the 
association between the means of patients and spouses was not statistically significant. The 
correlation between the HRQoL of patients and their spouses was weak (r=0.08-0.22).  
 
Association between demographic characteristics of the patients with prostate cancer and 
their HRQoL (RAND-36)  
An association was detected between the age, the presence of another disease and the 
treatment method of the patients with prostate cancer and their HRQoL (Table 3.). Patients 
who were 60 - 69 years old reported higher satisfaction with physical functioning and 
physical role functioning than those over 70. Patients with prostate cancer who also have the 
presence of other disease reported that their perceived physical role functioning and general 
health was lower than those patients who had no other diseases. An association was detected 
between the treatment method for prostate cancer and the dimension of perceived general 
health. Patients who receive surgical treatment perceived their general health to be better than 
those who would receive hormonal treatment. There was no evidence of an association 
between the HRQoL and basic education, vocational qualification, employment status or 
duration of the marital relationship.  
  
Association between the spouses’ demographic characteristics and their HRQoL (RAND-36) 
The associations between the demographic characteristics of the spouses and their HRQoL are 
presented in Table 4.  Their age was associated with physical functioning, physical and 
emotional role functioning and general health. Spouses who were younger than 60 years old 
reported higher satisfaction with physical functioning, physical role functioning and general 
health than those 70 or over. Spouses who were 60–69 years of age reported higher 
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satisfaction with emotional role functioning than those 70 or over. Their level of basic 
education was associated with general health. Those who had completed higher secondary 
education perceived their general health as better than those who had completed only 
elementary or civic school. Similarly, spouses who had a polytechnic or university degree 
perceived their health as better than those without a vocational qualification. Those who had 
no chronic disease perceived their physical functioning, physical role functioning, bodily 
painlessness and general health better than those who had a chronic disease. Neither 
employment status nor the duration of the marital relationship was associated with the 
HRQoL of the spouses. 
 
DISCUSSION 
 
Health-related of quality of life 
The main finding of this study was that the HRQoL of the patients with prostate cancer and 
their spouses was, on average, better on all dimensions when compared to the age- and 
gender-stratified Finnish population mean. Patients experienced better HRQoL compared to 
the age- and gender-stratified Finnish population mean on all eight dimensions. The findings 
lend support to past studies that have quantified the short-term impact of the prostate-specific 
antigen (PSA) screening process on the HRQoL (Vasarainen et al. 2013). In addition, with 
other instruments of HRQoL, parallel results have been obtained from Finnish patients with 
prostate cancer treated with radiotherapy, hormone therapy or palliative. As long as the 
disease remained localized, patients’ HRQoL remained at a relatively high level (Torvinen et 
al. 2013). Previous studies have showed that the quality of life of patients with prostate cancer 
treated with either surgery or radiation therapy was lower compared to the quality of life for 
the general population (Sanda et al. 2008, Mols et al. 2009). 
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The spouses in the present study experienced better HRQoL on all eight dimensions than the 
age- and gender-stratified Finnish population mean. Similar results have been found in other 
studies of partners of the patients with prostate cancer after treatment (Harden et al. 2013b). 
Potential changes in the quality of life might come forth in longitudinal studies of patients 
with prostate cancer and their spouses. Previous longitudinal studies have identified that 
spouses’ quality of life is associated with their spouses’ patient treatments for prostate cancer, 
especially if these patients report many side effects of their treatment (Green et al. 2011, 
Harden et al. 2013a). Our findings show that patients experienced mildly higher physical 
functioning, emotional well-being and painlessness than spouses.  On the other hand, spouses 
experienced higher physical role functioning than patients. An earlier study has shown that 
there is a connection between social support and quality of life of patients with prostate 
cancer (Queenan et al. 2010). Perhaps this partly explains why in this study quality of life the 
patients with prostate cancer was relatively high compared to the age- and gender-stratified 
Finnish population mean. Our study group included patients with prostate cancer who have 
the relationship to their spouses as permanent, which could, at least in part, explain the 
difference in the HRQoL between the reference populations. It may also be possible that, on 
average, healthier men and their spouses than patients with prostate cancer and their spouses 
usually may have participated in this survey.  
 
The characteristics of patients with prostate cancer  
The findings suggest that age, other diseases and the treatment method of patients with 
prostate cancer were associated with the HRQoL. Younger patients rated these dimensions of 
the quality of life better than older patients. The similar findings have been reported to the 
patient’s age from the effects of the health (Harju et al. 2012). Further, physical health 
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supposedly diminishes with age, which may be seen in the results of this study. On the other 
hand, previous studies have indicated that a younger age was associated with a poorer quality 
of life (Deimling et al. 2002, Harden et al. 2008, Wu & Harden 2015). In the patient data, 
chronic diseases were associated with physical functioning and also general health. In this 
study, the planned treatment method for prostate cancer was associated with general health. 
Patients who would receive hormonal treatment perceived their general health to be poorer 
than those who would receive surgical treatment. According to prostate cancer guidelines 
(Heidenreich et al. 2011) the HRQoL of patients with prostate cancer plays an important role 
in the choice of patient treatment option. The hormonal treatment will also be the primary 
alternative for the treatment of metastasized prostate cancer and for those patients where local 
radical treatment is not an option. The choice of treatment, thus, depends on the prostate 
cancer patient’s general condition and the patient’s age. (Heidenreich et al. 2011.)  
 
The characteristics of spouses 
Spouses who were younger than 60 years rated their physical functioning, physical and 
emotional role functioning and general health better than older spouses. The findings differ 
from those of a previous study (Wu & Harden 2015). However, patients who have other 
cancers than prostate cancer and their spouses also participated in Wu & Harden (2015) study. 
Other findings from a longitudinal study (Harden et al. 2013b) indicate that spouses who were 
younger than 65 years, perceived more threat and stress in their caregiving role, experienced 
more disturbance by their husbands’ post-treatment symptoms. In this study spouses who had 
higher basic education or vocational qualifications rated their general health better than those 
who had lower basic education or no vocational qualifications.  This is consistent with the 
results of other studies (Eton & Lepore 2002). In the patient data of this study, a similar 
significant association was not found. One explanation could be gender differences because 
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the women and men may experience and rate their quality of life differently. The chronic 
diseases of spouses were associated with weaker physical functioning, physical role 
functioning, bodily painlessness and general health.  These results are consistent because 
chronic diseases are likely to just affect the physical dimensions of HRQoL.  
 
The study has some limitations. The patients with prostate cancer included patients with 
different tumour stages and were not asked to report on characteristics such as stage, grade or 
disease status. On the other hand, the patients’ cancer treatments had not begun yet. The 
patients were not asked to describe their first symptom of prostate cancer. They were 
diagnosed with prostate cancer on the basis of the screening or the symptoms. This can have 
an effect on patients’ perceived quality of life. Potential first symptoms of the prostatic cancer 
can already affect patients’ HRQoL. Only patients with prostate cancer who characterized 
their relationship with their spouse as permanent were included in the study. This means that 
the results cannot be extrapolated to all patients with prostate cancer.  
 
In this study, Cronbach´s alpha coefficients for RAND-36 scales ranged from 0.85–0.87 in the 
patient and from 0.82–0.84 in the spouse data, demonstrating good internal consistency 
(Burns & Grove 2009). The representativeness of the sample is supported by the good 
response rate (65 %). The sample still is fairly small and selective.  The confounding factors 
such as family relationships or economic factors may also affect the results. Factors other than 
merely prostate cancer may have affected the HRQoL of the patients and their spouses. 
Although participants were asked to complete questionnaires separately, it is still possible that 
some couples discussed the questionnaire items together. Spouses were not asked to identify 
their gender, so in the analyses attention was not paid to same or separate sex couples. Self-
reported data on treatment are limited by patients’ understanding and recall of treatments. 
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Overall, the findings support previous research regarding giving consideration to both 
patients’ and their spouses’ quality of life in both research and clinical practice. 
 
CONCLUSION 
 
In summary, in this study, patients with prostate cancer who characterized the relationship 
with their spouse as permanent experienced their HRQoL as relatively good compared with 
the general population. Their counselling and support should thus focus on emotional well-
being, because this dimension was found to be closest to the age- and gender-stratified 
population mean. The results further added nurses’ knowledge of the HRQoL on the patients 
with prostate cancer and their spouses. Counselling and support of patients with prostate 
cancer should be more family-focused and focus on emotional well-being, because this 
dimension was found to be the closest to the age- and gender-stratified population mean for 
both the patients and their spouses. In addition, nurses should pay more attention to couples 
older than 70 years who have other chronic diseases or receive hormonal treatment. It is 
important that at the time of diagnosis, all spouses will be considered and noticed for 
counseling, support and advise because spouses are important supporters of those patients 
with prostate cancer.    
 
Further longitudinal follow-up studies are still essential to identify the changes in the HRQoL 
and any related factors that are affecting patients and their spouses during and after prostate 
cancer treatment. Based on this information, timely interventions can then be developed to 
support patients with prostate cancer and their spouses. Also, it is important to recognize 
those couples with low HRQoL and focus these interventions on them.    
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 Table 1 Demographic characteristics of patients with prostate cancer (n=232) and their 
spouses (n=229) 
 Patients  Spouses  
Variable n % n % 
Age years 
 59 
60–69 
 70  
 
42 
98 
92 
 
18 
42 
40 
 
60 
104 
65 
 
26 
46 
28 
Duration of marital relationship (years) 
 25 
26–40 
 41 
 
57 
58 
116 
 
25 
25 
50 
  
Basic education 
Elementary school/civic school 
Comprehensive school/lower 
Secondary school 
Upper secondary school 
 
148 
49 
 
35 
 
64 
21 
 
15 
 
108 
61 
 
60 
 
47 
27 
 
26 
Vocational qualifications 
Initial vocational qualification 
Further vocational qualification 
Polytechnic/university degree 
No vocational qualification 
 
69 
59 
23 
76 
 
30 
26 
10 
34 
 
65 
71 
31 
55 
 
29 
32 
14 
25 
Employment status 
Working 
Not working 
 
99 
133 
 
43 
57 
 
107 
122 
 
47 
53 
Chronic diseases 
Yes 
No 
 
160 
72 
 
69 
31 
 
147 
82 
 
64 
36 
Treatment method 
Surgery 
Radiation therapy 
Hormonal treatment 
Non-invasive care 
 
62 
32 
53 
80 
 
27 
14 
23 
36 
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Table 2. RAND 36-item health survey mean scores of the patients with prostate cancer (n=232) and their spouses (n=229) 
Quality of life 
dimension 
Items Patients 
 
 
M† 
 
 
 
SD 
 
 
RAND 
average‡ 
 
 
 
SD 
Patients/
RAND 
average 
p-value* 
Spouses 
 
 
M† 
 
 
 
SD 
 
 
RAND 
average‡ 
 
 
 
SD 
Spouses/ 
RAND 
average 
p-value* 
Patients/ 
Spouses 
 
p-value* 
Social functioning 2 82.4 22.4 77.6 5.9 <0.001 85.3 17.9 78.6 1.8 <0.001 0.261 
Physical 
functioning 
10 81.0 21.3 68.1 10.3 <0.001 78.7 20.5 66.5 12.1 <0.001 0.176 
Emotional well-
being 
5 76.0 16.3 74.5 2.6 0.028 76.0 15.1 73.7 2.0 0.007 0.938 
Bodily pain 2 75.7 23.1 67.8 6.3 <0.001 74.0 22.9 65.9 5.1 <0.001 0.463 
Role 
functioning/emoti
onal 
3 69.8 39.0 63.5 10.4 0.032 73.1 35.8 63.8 8.5 <0.001 0.267 
Energy 4 67.5 21.1 62.7 5.8 <0.001 68.1 18.8 59.8 3.6 <0.001 0.956 
Role 
functioning/physi
cal 
4 65.6 40.9 54.7 12.3 0.003 70.4 37.2 54.1 13.0 <0.001 0.173 
General health 5 59.1 17.8 50.6 4.6 <0.001 61.6 17.7 52.8 6.3 <0.001 0.156 
† Scale: 0: poor health and quality of life – 100: good health and quality of life 
‡ Age-stratified general male / female populations (16) * Wilcoxon Signed Ranks test 
Significant P value in boldface (P < 0.05). 
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Table 3. Association between the demographic characteristics of patients with prostate cancer (n=232) and their HRQOL (RAND-36) 
 Physical 
functioning 
Role 
functioning/ 
physical 
Role 
functioning/ 
emotional 
Energy Emotional 
well-being 
Social 
functioning 
Bodily pain General health  
Variable M (SD)  
p-value 
M (SD)  
p-value 
M (SD)  
p-value 
M (SD)  
p-value 
M (SD)  
p-value 
M (SD)  
p-value 
M (SD)  
p-value 
M (SD)  
p-value 
Age years 
 59 
60–69 
 70 
<0.001 
80.6 (24.7) 
86.9 (15.6) 
74.6 (23.4) 
<0.001 
63.4 (41.9) 
78.9 (34.9) 
52.2 (42.4) 
0.117 
65.0 (42.1) 
77.0 (34.1) 
64.0 (41.6) 
0.005 
60.0 (23.0) 
72.6 (17.6) 
65.5 (22.6) 
0.056 
70.5 (18.8) 
77.8 (15.9) 
76.6 (15.0) 
0.086 
78.0 (27.8) 
86.6 (18.0) 
79.9 (23.6) 
0.059 
70.2 (27.9) 
80.2 (20.2) 
73.3 (23.1) 
0.012 
60.9 (19.0) 
62.3 (16.8) 
54.7 (17.9) 
Other disease 
Yes 
No 
<0.001 
77.4 (22.6) 
88.6 (16.0) 
0.010 
60.5 (42.6) 
76.7 (34.7) 
0.108 
66.9 (40.3) 
75.9 (35.5) 
0.114 
65.8 (22.1) 
71.2 (18.4) 
0.026 
74.2 (17.0) 
79.8 (13.9) 
0.055 
80.6 (23.2) 
86.3 (20.2) 
0.003 
72.6 (24.4) 
82.5 (18.6) 
<0.001 
55.4 (18.2) 
67.0 (14.2) 
Treatment method 
Surgery 
Radiation therapy 
Hormonal treatment 
Non-invasive care 
0.015 
83.4 (19.8) 
84.7 (15.4) 
71.1 (26.2) 
83.3 (19.9) 
0.009 
73.8 (38.6) 
60.2 (37.5) 
50.5 (45.0) 
70.6 (39.2) 
0.103 
76.0 (37.6) 
65.6 (40.1) 
59.3 (41.7) 
72.6 (37.7) 
0.131 
71.6 (17.3) 
68.8 (21.2) 
59.7 (24.4) 
68.3 (20.6) 
0.350 
78.6 (14.5) 
75.1 (15.8) 
72.5 (17.8) 
76.0 (16.8) 
0.009 
83.8 (21.8) 
82.4 (20.8) 
73.5 (25.2) 
86.3 (21.0) 
0.018 
79.0 (20.2) 
79.7 (18.7) 
64.6 (26.9) 
77.8 (23.1) 
<0.001 
66.7 (15.7) 
60.9 (15.3) 
49.0 (17.5) 
58.5 (18.1) 
The p-values in boldface have been adjusted according to the Bonferroni correction 
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Table 4. Association between the demographic characteristics of spouses (n=229) and their HRQOL (RAND-36) 
 Physical 
functioning 
Role functioning/ 
physical 
Role functioning/ 
emotional 
Energy Emotional 
well-being 
Social 
functioning 
Bodily pain General health  
Variable M (SD)   
p-value 
M (SD)  
p-value 
M (SD)  
p-value 
M (SD)  
p-value 
M (SD)  
p-value 
M (SD) 
 p-value 
M (SD)  
p-value 
M (SD)  
p-value 
Age years 
 59 
60–69 
 70 
<0.001 
86.2 (16.8) 
80.3 (19.4) 
70.4 (22.4) 
<0.001 
85.7 (25.9) 
72.0 (37.3) 
55.5 (40.2) 
<0.001 
80.8 (30.5) 
81.5 (31.8) 
55.8 (40.7) 
0.109 
64.5 (21.2) 
71.1 (17.1) 
70.0 (17.9) 
0.336 
74.2 (16.0) 
77.6 (14.9) 
75.1 (14.6) 
0.134 
84.8 (18.3) 
87.9 (16.0) 
81.8 (19.7) 
0.119 
76.5 (21.8) 
75.9 (21.7) 
69.5 (24.9) 
<0.001 
68.3 (18.2) 
62.9 (17.4) 
54.8 (15.3) 
Basic education 
Elementary/civic school 
Comprehensive/lower 
secondary school 
Upper secondary school 
0.001 
75.0 (20.6) 
79.9 (20.8) 
 
85.3 (18.5) 
0.122 
64.9 (39.6) 
73.4 (35.0) 
 
78.0 (33.2) 
0.004 
65.7 (38.7) 
79.8 (33.5) 
 
82.5 (30.5) 
0.529 
70.1 (17.1) 
66.5 (19.7) 
 
66.4 (20.1) 
0.957 
75.8 (15.8) 
75.9 (14.0) 
 
76.3 (15.1) 
0.347 
84.1 (18.0) 
85.9 (17.9) 
 
86.9 (17.4) 
0.106 
72.4 (22.8) 
72.3 (24.3) 
 
79.4 (20.4) 
<0.001 
57.8 (16.3) 
61.1 (18.4) 
 
69.3 (16.9) 
Vocational qualifications 
Initial vocational qualification 
Further vocational 
qualification 
Polytechnic/university degree 
No vocational qualification 
0.004 
75.9 (19.8) 
81.6 (21.7) 
 
87.0 (15.5) 
75.6 (21.6) 
0.220 
65.4 (37.2) 
73.9 (35.7) 
 
81.7 (30.0) 
68.1 (41.0) 
0.057 
72.8 (36.7) 
78.4 (34.3) 
 
84.4 (31.2) 
66.7 (37.1) 
0.925 
67.8 (17.9) 
68.3 (18.6) 
 
67.3 (20.9) 
67.4 (19.2) 
0.357 
75.5 (15.5) 
76.6 (14.4) 
 
78.7 (14.6) 
73.5 (16.4) 
0.095 
84.2 (17.0) 
85.4 (18.1) 
 
90.8 (16.1) 
82.6 (19.5) 
0.049 
70.1 (23.7) 
75.0 (24.1) 
 
83.3 (16.8) 
72.3 (22.3) 
<0.001 
58.6 (18.0) 
65.2 (17.6) 
 
71.0 (15.8) 
56.6 (16.3) 
Chronic diseases 
Yes 
No 
<0.001 
74.0 (21.9) 
88.0 (13.8) 
<0.001 
60.8 (39.5) 
88.0 (24.1) 
0.006 
69.2 (37.5) 
82.3 (31.7) 
0.025 
66.1 (19.3) 
71.8 (16.9) 
0.363 
75.2 (15.6) 
77.3 (14.1) 
0.001 
82.4 (19.1) 
90.4 (13.9) 
<0.001 
68.5 (23.5) 
84.4 (17.4) 
<0.001 
56.9 (16.7) 
70.3 (16.0) 
The p-values in boldface have been adjusted according to the Bonferroni correction.
